Order Article Reprints

Mattos M, Sacramento CQ, Ferreira AC, Fintelman-Rodrigues N, Pereira-Dutra FS, de Freitas CS, Gesto JSM, Temerozo JR, Silva AdPDD, Moreira MTG, et al. Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice. Viruses. 2024; 16(12):1856. https://doi.org/10.3390/v16121856

Mattos, Mayara, Carolina Q. Sacramento, André C. Ferreira, Natalia Fintelman-Rodrigues, Filipe S. Pereira-Dutra, Caroline Souza de Freitas, João S. M. Gesto, Jairo R. Temerozo, Aline de Paula Dias Da Silva, Mariana T. G. Moreira, and et al. 2024. "Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice" Viruses 16, no. 12: 1856. https://doi.org/10.3390/v16121856

Mattos, M., Sacramento, C. Q., Ferreira, A. C., Fintelman-Rodrigues, N., Pereira-Dutra, F. S., de Freitas, C. S., Gesto, J. S. M., Temerozo, J. R., Silva, A. d. P. D. D., Moreira, M. T. G., Silva, R. S. C., Silveira, G. P. E., Pinto, D. P., Pereira, H. M., Fonseca, L. B., Alves Ferreira, M., Blanco, C., Viola, J. P. B., Bou-Habib, D. C., ... Souza, T. M. L. (2024). Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice. Viruses, 16(12), 1856. https://doi.org/10.3390/v16121856